Smith & Nephew plc (SNN) - צמיחת רווחים בשנה הנוכחית

Smith & Nephew plc (SNN) dominates wound care and orthopedics, creating clinic dependency on its ecosystems. The 12-month relative EPS growth rate confirms this strategy, with the value holding at 4.80. Surgical robotization minimizes physician errors during implant placement, while Deepak Nath's team is gradually stabilizing margins within the surgical segment.

This indicator measures the relative dynamics of earnings per share, reflecting the business's ability to scale profitability relative to the previous year's base. For Smith & Nephew plc (SNN), whose positions are protected by patents and the complexity of replacing surgical equipment, the annual EPS growth trajectory confirms the effective monetization of its technological leadership in orthopedics, even amidst macroeconomic volatility.